Adjuvant Nutrition for Critically Ill Trauma Patients
Completed · Phase 1
Conditions studied: Trauma
In brief
Of the four million trauma cases each year that will require hospitalization, 200,000 will be classified as severe trauma. During the hospital stay, malnutrition is a major complication in about 50% of the patient population. The result is muscle wasting which is a major risk factor for increased morbidity and mortality. In this study we postulate that supplementation with beta-hydroxy-beta-methylbutyrate (HMB), arginine and glutamine (HMB/Arg/Gln)or HMB alone to these severely traumatized patients can stem the loss of muscle tissue and whole body nitrogen and in turn decrease morbidity and mortality. This hypothesis is based on two recent studies showing the same nutritional mixture of HMB/Arg/Gln can reverse the muscle wasting associated with AIDS and Cancer. The hypermetabolic state seen in AIDS and cancer have a similar multifactorial etiology as seen in trauma. There is an increase in the mobilization of fat and muscle, increased or normal metabolic rate, increased protein breakdown, and an increased or normal glucose turnover. In addition, HMB alone has been shown to reduce nitrogen loss, decrease muscle proteolysis and muscle damage within the first 48 hours to three weeks after initiating supplementation during a strenuous exercise program. Male and female patients (n=100) will be recruited at the time of admittance to the Trauma ICU with an ISS of greater than 18. Patients who meet the inclusion/exclusion criteria will be randomized to receive either 1) standard tube feed plus HMB/Arg/Gln, 2) standard tube feed plus HMB alone, or 3)standard tube feed (control) in a double-blinded fashion. Clinical outcomes measures will be assessed through out the hospital stay and on an outpatient basis at weeks 4 and 12. Muscle proteolysis and nitrogen economy will be evaluated on daily basis while in the hospital and after 4 weeks on an out patient basis. If as expected, Phase I results confirm the effectiveness of the nutrient mixture in trauma patients, expanded multicenter studies will be proposed in Phase II.
Key facts
- Study ID
- NCT00067132
- Run by
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- People needed
- 100
- Starts
- 2003-03-01
- Last updated by the study team
- 2010-01-14
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Critically injured trauma patients with an Injury Severity Score (ISS) >18
- Candidate for enteral feeding
- Life expectancy >48 hours
- Total Bilirubin less than or equal to 2.5 mg/dl
- Serum Creatinine less than 3.0 mg/dl.
- Must be able to start supplements within 72 h
- Patient must reside in geographical area of Las Vegas, Nevada
You may not qualify if…
- Pregnant
- Genetic or immune disorder
- Known hepatitis
- 3rd degree burns involving more than 15% of the body
- Use of other investigational drugs
- Steroid use
- Malignancy
- HIV
- Congestive heart failure
- Inflammatory bowel disease
- Implanted pacemaker or defibrillator
Where it is running
- University Medical Trauma Center/UNSOM — Las Vegas, Nevada, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.